Posted on 2/28/19
A Tale of 2 M&As: The Kraft Heinz Debacle, and Danaher's Pickup of GE Biopharma
The world of mergers and acquisitions is a peculiar place. On the one hand, you have activists demanding that large businesses sell off pieces of their . . .
Posted on 2/28/19
NanoViricides Announces $2.5 Million Financing
NanoViricides, Inc. (NYSE MKT: NNVC) a global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announced today that it . . .
Posted on 2/27/19
MeiraGTx Announces $80 Million Private Placement of Ordinary Shares
LONDON and NEW YORK, Feb. 27, 2019 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that it . . .
Posted on 2/27/19
Genesis Drug Discovery & Development Announces Operating Agreement with Ophthy-DS
PharmOptima, a member of Genesis Drug Discovery & Development (GD3), the contract research organization (CRO) arm of Genesis Biotechnology Group (GBG), and Ophthy-DS, a preclinical CRO . . .
Posted on 2/27/19
The Medicines Company Reports Fourth-Quarter and Full Year 2018 Business and Financial Results
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO) today reported its financial results for the fourth quarter and full year ended December 31, 2018.“During 2018 we successfully . . .
Posted on 2/27/19
Better Buy: GlaxoSmithKline vs. Eli Lilly
If you haven't looked at GlaxoSmithKline (NYSE:GSK) and Eli Lilly (NYSE:LLY) in several years, you probably wouldn't recognize them today. Eli Lilly recently spun off its . . .
Posted on 2/26/19
Santéch Named A Major Player in the IDC MarketScape for Provider Data Management
Santéch has been positioned as a Major Player in IDC MarketScape*: U.S. Provider Data Management 2018 Vendor Assessment (doc #US44514018, December 2018). The IDC MarketScape provides . . .
Posted on 2/26/19
Premier Health Expands Technology Development Team
Premier Health Group (CSE: PHGI) (OTCQB: PHGRF) (Frankfurt: 6PH), a Company focused on developing innovative approaches that combine human skill-based expertise with emerging technologies for the . . .
Posted on 2/26/19
Henry Schein Named One Of The 2019 World's Most Ethical Companies By Ethisphere
Henry Schein, Inc. (Nasdaq: HSIC),the world's largest provider of health care products and services to office-based dental and medical practitioners, has been recognized by the Ethisphere . . .
Posted on 2/26/19
Better Buy: Eli Lilly vs. Johnson & Johnson
Two of America's oldest healthcare stocks have been acting out of character lately. After years of stagnation, shares of Eli Lilly (NYSE:LLY) surged in 2018 along . . .
Posted on 2/26/19
General Electric: $21 Billion Biopharma Sale Sends Shock Waves
Summary GE's $21B biopharma sale is a masterstroke. It puts a sizable dent in GE's $110 billion debt load and improves its credit metrics. However, GE's . . .
Posted on 2/25/19
EmblemHealth Family of Companies Announces Affiliation with BronxDocs Primary and Specialty Care
EmblemHealth, one of the nation's largest non-profit health insurers, announced today an affiliation with BronxDocs. BronxDocs opened two new offices delivering primary and specialty care to . . .
Posted on 2/25/19
Hoth Therapeutics Adds Dr. Adam Friedman, M.D. to the Company's Scientific Advisory Board
Hoth Therapeutics, Inc.(NASDAQ:HOTH), a development stage biopharmaceutical company focused on unique targeted therapeutics for patients
Posted on 2/25/19
Melinta Therapeutics Closes Initial $75M Vatera Convertible Loan Funding
MORRISTOWN, N.J., Feb. 25, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to . . .
Posted on 2/25/19
Mallinckrodt Announces Extracorporeal Photopheresis Research Collaboration Agreement With Transimmune AG
Mallinckrodt Pharmaceuticals (NYSE:MNK), a leading global specialty pharmaceutical company, today announced it has entered into a research collaboration agreement with Transimmune AG, a company developing novel . . .
Posted on 2/25/19
Ortho Clinical Diagnostics Wins Stevie Award for Customer Service and Support
Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, has been awarded a Stevie® Award for Customer Service Department of the Year for its Ortho . . .
Posted on 2/25/19
Spark Therapeutics To Merge With Roche
Spark Therapeutics (NASDAQ: ONCE), a fully integrated, commercial gene therapy company dedicated to challenging the inevitability of genetic disease
Posted on 2/25/19
Better Buy: Amgen vs. Celgene
If you're looking to invest in successful big biotechs, two of the biggest are Amgen(NASDAQ:AMGN) and Celgene (NASDAQ:CELG). Over the past 10 years, both stocks have . . .
Posted on 2/22/19
What Pharma Investors Need to Know About Pfizer's Latest Disaster
Pfizer (NYSE:PFE) recently shared some unfortunate news related to its blockbuster anti-inflammation drug, Xeljanz. A safety problem for this popular tablet could open doors for similar . . .
Posted on 2/21/19
Ohr Pharmaceutical Regains Compliance with NASDAQ Listing Requirements
NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) today announced that it received notice from The Nasdaq Stock Market LLC indicating . . .
Posted on 2/21/19
CareDox and PowerSchool Announce Partnership
CareDox, the nation's largest provider of healthcare software and services for K-12 school districts, today announced a new partnership with PowerSchool, a leading provider of K-12 . . .
Posted on 2/21/19
Merck to Acquire Immune Design for $300M
Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Immune Design (NASDAQ:IMDZ)
Posted on 2/21/19
Better Buy: Pfizer vs. Eli Lilly
Large pharmaceutical companies generate healthy cash flows, part of which they usually return to shareholders in the form of dividends and share buybacks. But these businesses . . .
Posted on 2/21/19
Hoth Therapeutics Closes IPO
NEW YORK, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Hoth Therapeutics Inc., a development stage biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications . . .
Posted on 2/20/19
Quest Diagnostics Partners With Houston Healthcare
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Houston Healthcare are teaming up to enhance the quality and value of diagnostic . . .

